Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 4:30 AM
Ignite Modification Date:
2025-12-25 @ 4:30 AM
NCT ID:
NCT00987818
Eligibility Criteria:
Inclusion Criteria:
* Patients admitted to the ICU
* Age \> 18 years
* Antibiotic therapy for sepsis with a suspected or proven focus of infection
Exclusion Criteria:
* Age \< 18 years
* Pregnancy
* Infection or presumed infection requiring prolonged antibiotic therapy (osteomyelitis, meningitis, endocarditis, septic arthritis, mediastinitis, tuberculosis, Pneumocystis jiroveci pneumonia, Toxoplasmosis, Legionellosis, Listeriosis)
* Indication for prolonged systemic prophylactic antibiotic therapy
* Severe viral or parasitic infections (hemorrhagic fever, malaria)
* Antibiotic therapy started 48 hours before enrollment
* Severe immunocompromised patients (AIDS with a CD4 count \< 200cells/mm3, severe neutropenia(\<500 neutrophils/mm3), patients undergoing immunosuppressive therapy after solid organ transplantation)
* Patients foregoing life sustaining treatment
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT00987818
Study Brief:
Protocol Section:
NCT00987818